Enhanced antitumoral activity of TLR7 agonists via activation of human endogenous retroviruses by HDAC inhibitors

MLA

David Díaz-Carballo, et al. “Enhanced Antitumoral Activity of TLR7 Agonists via Activation of Human Endogenous Retroviruses by HDAC Inhibitors.” Communications Biology, vol. 4, no. 1, Mar. 2021, pp. 1–16. EBSCOhost, https://doi.org/10.1038/s42003-021-01800-3.

APA

David Díaz-Carballo, Sahitya Saka, Ali H. Acikelli, Ekaterina Homp, Julia Erwes, Rebecca Demmig, Jacqueline Klein, Katrin Schröer, Sascha Malak, Flevy D’Souza, Adrien Noa-Bolaño, Saskia Menze, Emilio Pano, Swetlana Andrioff, Marc Teipel, Philip Dammann, Diana Klein, Amber Nasreen, Andrea Tannapfel, … Dirk Strumberg. (2021). Enhanced antitumoral activity of TLR7 agonists via activation of human endogenous retroviruses by HDAC inhibitors. Communications Biology, 4(1), 1–16. https://doi.org/10.1038/s42003-021-01800-3

Chicago

David Díaz-Carballo, Sahitya Saka, Ali H. Acikelli, Ekaterina Homp, Julia Erwes, Rebecca Demmig, Jacqueline Klein, et al. 2021. “Enhanced Antitumoral Activity of TLR7 Agonists via Activation of Human Endogenous Retroviruses by HDAC Inhibitors.” Communications Biology 4 (1): 1–16. doi:10.1038/s42003-021-01800-3.